HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alvin J Beitz Selected Research

GABA-A Receptor Antagonists

11/2010An increase in spinal dehydroepiandrosterone sulfate (DHEAS) enhances NMDA-induced pain via phosphorylation of the NR1 subunit in mice: involvement of the sigma-1 receptor.
6/2009Intrathecal injection of the neurosteroid, DHEAS, produces mechanical allodynia in mice: involvement of spinal sigma-1 and GABA receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alvin J Beitz Research Topics

Disease

43Hyperalgesia
12/2021 - 01/2003
39Pain (Aches)
12/2021 - 02/2001
20Neuralgia (Stump Neuralgia)
12/2021 - 08/2004
16Inflammation (Inflammations)
01/2018 - 01/2003
7Neoplasms (Cancer)
05/2016 - 01/2003
5Hypersensitivity (Allergy)
02/2018 - 08/2011
5Arthritis (Polyarthritis)
12/2004 - 02/2001
4Peripheral Nervous System Diseases (PNS Diseases)
11/2019 - 08/2004
4Thrombosis (Thrombus)
01/2014 - 10/2008
4Ischemia
01/2012 - 10/2008
4Edema (Dropsy)
03/2008 - 02/2001
3Peripheral Nerve Injuries
08/2019 - 01/2017
3Chronic Pain
01/2013 - 08/2004
3Fibrosarcoma
09/2007 - 01/2003
2Hypotension (Low Blood Pressure)
05/2016 - 03/2009
2Bone Neoplasms (Bone Cancer)
11/2014 - 01/2003
2Cancer Pain
11/2014 - 01/2013
2Hypoxia (Hypoxemia)
01/2014 - 10/2008
2Spinal Cord Injuries (Spinal Cord Injury)
01/2013 - 07/2010
2Acidosis
03/2011 - 08/2010
2Sarcoma (Soft Tissue Sarcoma)
02/2009 - 01/2003
2Multiple Sclerosis
06/2008 - 01/2008
2Rheumatoid Arthritis
05/2002 - 02/2001
1Migraine Disorders (Migraine)
02/2018
1Acute Pain
01/2018

Drug/Important Bio-Agent (IBA)

13Bee Venoms (Bee Venom)IBA
03/2016 - 02/2001
10Sigma-1 ReceptorIBA
12/2021 - 12/2008
10N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2021 - 06/2006
9Analgesics (Analgesic Drugs)IBA
12/2021 - 02/2001
8N-Methylaspartate (NMDA)IBA
12/2021 - 02/2010
8CarrageenanIBA
01/2018 - 01/2003
7Formaldehyde (Formol)FDA Link
01/2018 - 03/2003
7N- (2- (3,4- Dichlorphenyl)ethyl)- N,N',N'- trimethyl- 1,2- ethandiaminIBA
12/2016 - 06/2006
6Capsaicin (Zostrix)FDA Link
02/2018 - 09/2007
52- (4- morpholino)ethyl- 1- phenylcyclohexane- 1- carboxylateIBA
12/2021 - 11/2008
5EnzymesIBA
10/2019 - 01/2019
5Clonidine (ST 155)FDA LinkGeneric
05/2016 - 07/2008
5Adrenergic Receptors (Adrenergic Receptor)IBA
05/2016 - 11/2011
4NeurosteroidsIBA
10/2019 - 06/2009
4CytochromesIBA
10/2019 - 01/2019
4p38 Mitogen-Activated Protein KinasesIBA
10/2019 - 09/2013
4Proteins (Proteins, Gene)FDA Link
08/2019 - 05/2005
4Serine (L-Serine)FDA Link
01/2019 - 10/2015
4Morphine (MS Contin)FDA LinkGeneric
11/2014 - 01/2003
4Opioid Analgesics (Opioids)IBA
11/2014 - 02/2004
4CatecholaminesIBA
10/2007 - 09/2005
3Ketoconazole (Nizoral)FDA LinkGeneric
10/2019 - 01/2019
3SB 203580IBA
10/2019 - 04/2014
3Messenger RNA (mRNA)IBA
08/2019 - 09/2007
3Dehydroepiandrosterone (DHEA)IBA
08/2019 - 06/2009
3LigandsIBA
01/2019 - 09/2007
3Purinergic P2Y1 ReceptorsIBA
01/2017 - 01/2014
3Adenosine Triphosphate (ATP)IBA
01/2014 - 08/2010
3ZymosanIBA
05/2007 - 07/2005
3Freund's AdjuvantIBA
12/2002 - 02/2001
2Interleukin-1 Receptors (Interleukin 1 Receptor)IBA
12/2021 - 01/2017
2Protein Isoforms (Isoforms)IBA
11/2019 - 06/2010
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2019 - 01/2017
2serine racemaseIBA
01/2019 - 01/2017
2fluorocitrateIBA
01/2019 - 12/2016
2Connexin 43 (Connexin43)IBA
01/2017 - 12/2016
22- iodo- N(6)- methyl- (N)- methanocarba- 2'- deoxyadenosine- 3',5'- bisphosphateIBA
01/2017 - 04/2014
2Mitogen-Activated Protein KinasesIBA
01/2017 - 04/2014
2CarbenoxoloneIBA
12/2016 - 07/2010
2Peptides (Polypeptides)IBA
12/2016 - 09/2007
2Oxaliplatin (Eloxatin)FDA LinkGeneric
05/2016 - 03/2016
2Opiate AlkaloidsIBA
11/2014 - 01/2008
2Therapeutic UsesIBA
01/2013 - 02/2001
2Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
02/2012 - 09/2008
2Pharmaceutical PreparationsIBA
03/2011 - 08/2008
2BicucullineIBA
11/2010 - 06/2009
2GABA-A Receptor AntagonistsIBA
11/2010 - 06/2009
2Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
02/2010 - 08/2008
2Gabapentin (Neurontin)FDA LinkGeneric
08/2008 - 09/2007
2Neostigmine (Neostigmine Bromide)IBA
07/2008 - 09/2005
2Opioid Receptors (Opioid Receptor)IBA
01/2008 - 08/2004
12- ((1H- benzo(d)(1,2,3)triazol- 5- ylamino)methyl)- 4,6- dichlorophenolIBA
11/2019
1Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
11/2019
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
08/2019
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2019
1Aminoglutethimide (Cytadren)FDA Link
01/2019
1trilostaneFDA Link
01/2019
1Oxidoreductases (Dehydrogenase)IBA
01/2019
1Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2018
1resiniferatoxinIBA
02/2018
1Nitroglycerin (Dynamite)FDA LinkGeneric
02/2018
1Aromatase (CYP19)IBA
01/2018
1D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA
01/2017
1InterleukinsIBA
01/2017
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
01/2017

Therapy/Procedure

10Acupuncture Points (Acupuncture Point)
03/2016 - 02/2001
5Spinal Injections
12/2016 - 11/2008
5Electroacupuncture
01/2013 - 01/2006
4Therapeutics
01/2013 - 02/2001
3Drug Therapy (Chemotherapy)
05/2016 - 01/2003
2Injections
01/2014 - 02/2001
2Acupuncture Therapy
01/2013 - 01/2006
2Complementary Therapies (Alternative Medicine)
01/2013 - 02/2001
2Subcutaneous Injections
03/2009 - 02/2005
2East Asian Traditional Medicine (Oriental Medicine)
08/2004 - 02/2001